Posts

Posted on

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—CRBG, OLPX, FONR, and CTRA

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

  • Corebridge Financial, Inc. (NYSE: 

    CRBG

    ) related to its merger with Equitable Holdings, Inc. Upon closing of the proposed transaction, Corebridge shareholders will own approximately 51% of the combined company.

Click here for more information

https://monteverdelaw.com/case/corebridge-financial-inc/

. It is free and there is no cost or obligation to you.

  • Olaplex Holdings, Inc. (NASDAQ: 

    OLPX

    ) related to its sale to Henkel US Operations Corporation. Under the terms of the proposed transaction, Olaplex shareholders are expected to receive $2.06 per share in cash.

Click here for more information

https://monteverdelaw.com/case/olaplex-holdings-inc/

. It is free and there is no cost or obligation to you.

  • FONAR Corporation (NASDAQ: 

    FONR

    ) related to its sale to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, FONAR’s Class B common stockholders will receive $19.00 per share and FONAR’s Class C common stockholders will receive $6.34 per share.

Click here for more information

https://monteverdelaw.com/case/fonar-corporation/

. It is free and there is no cost or obligation to you.

  • Coterra Energy, Inc. (NYSE: 

    CTRA

    ) related to its sale to Devon Energy Corporation. Under the terms of the proposed transaction, Coterra shareholders will receive 0.70 of a share of Devon common stock for each share of Coterra common stock.

ACT NOW. The Shareholder Vote is scheduled for May 4, 2026.

Click here for more info

https://monteverdelaw.com/case/coterra-energy-inc/

.
It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  1. Do you file class actions and go to Court?
  2. When was the last time you recovered money for shareholders?
  3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.



Posted on

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—WBD, EQH, ULY, and NSA

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) —

Class Action Attorney
Juan Monteverde
with

Monteverde & Associates PC
 (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

  • Warner Bros. Discovery, Inc. (NASDAQ: 

    WBD

    )  related to its sale to Paramount Skydance Corporation. Under the terms of the proposed transaction, Warner Bros. shareholders are expected to receive (i) $31.00 per share in cash and (ii) a ticking consideration of $0.00277778 multiplied by the number of calendar days elapsed after September 30, 2026.

ACT NOW. The Shareholder Vote is scheduled for April 23, 2026.

Click here for more information

https://monteverdelaw.com/case/warner-bros-discovery-inc-2/

. It is free and there is no cost or obligation to you.

  • Equitable Holdings, Inc. (NYSE: 

    EQH

    ) related to its merger with Corebridge Financial, Inc. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company.

Click here for more information

https://monteverdelaw.com/case/equitable-holdings-inc/

. It is free and there is no cost or obligation to you.

  • Urgent.ly, Inc. (NASDAQ: 

    ULY

    )  related to its sale to Agero, Inc. Under the terms of the proposed transaction, Urgent.ly shareholders are expected to receive $5.50 per share in cash.

ACT NOW. The Tender Offer expires on April 24, 2026.

Click here for more information

https://monteverdelaw.com/case/urgent-ly-inc/

. It is free and there is no cost or obligation to you.

  • National Storage Affiliates Trust (NYSE: 

    NSA

    ) related to its sale to Public Storage. Under the terms of the proposed transaction, National Storage shareholders are expected to receive 0.14 of a share of Public Storage common stock or partnership units for each National Storage share or unit.

Click here for more info

https://monteverdelaw.com/case/national-storage-affiliates-trust/

.
It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

  1. Do you file class actions and go to Court?
  2. When was the last time you recovered money for shareholders?
  3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.



Posted on

Corning and Meta Celebrate Start of Construction on Cable Manufacturing Expansion in North Carolina to Support AI Buildout

Corning and Meta Celebrate Start of Construction on Cable Manufacturing Expansion in North Carolina to Support AI Buildout

New capacity will supply advanced data centers with U.S.-made technology

CORNING, N.Y.–(BUSINESS WIRE)–CorningIncorporated (NYSE: GLW) and Meta Platforms, Inc. (Nasdaq: META) today marked the start of construction on a significant expansion of Corning’s optical cable manufacturing capacity in Hickory, North Carolina, reinforcing their collaboration to support the buildout of advanced AI data centers using technology developed and manufactured in the United States.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331275717/en/

Leaders from Corning, Meta, and state and local government break ground for Corning's new cable manufacturing facility in Hickory, NC

Leaders from Corning, Meta, and state and local government break ground for Corning’s new cable manufacturing facility in Hickory, NC

The groundbreaking marks a milestone in the multiyear, up to $6 billion agreement between Corning and Meta to accelerate the deployment of the most advanced data centers in the U.S. and to support Meta’s apps, technologies, and AI objectives. Under the agreement, which was announced in January of this year, Corning will supply Meta with its newest innovations in optical fiber, cable, and connectivity solutions. Meta will serve as the anchor customer for the Hickory expansion, which will produce optical cable critical to AI infrastructure.

“As America advances its lead in AI, the infrastructure we build today will determine whether we stay ahead tomorrow. High-performance connectivity is at the heart of this work,” said Dan Sachs, Meta’s Vice President of Public Policy – State and Local. “Our partnership with Corning supports our goal of strengthening domestic manufacturing, supporting good jobs in North Carolina, and building a foundation for the next era of American innovation.”

“Today we are breaking ground on a new state-of-the-art manufacturing facility in a critical next step for strengthening the domestic supply chain for AI data centers,” said Hal Nelson, Chief Operating Officer, Corning Incorporated. “Our expansion here in Hickory also opens a new chapter in our longstanding partnership with Meta. It’s a great example of the kind of collaboration Corning values most – helping our customers solve tough challenges by working together to move at the speed and scale that delivers the solutions they need.”

Corning, which currently employs more than 5,000 people in North Carolina, will expand manufacturing capabilities across the state to support the agreement with Meta. The expansion could increase Corning’s employment levels in the state by 15 to 20 percent, reinforcing North Carolina’s role as a manufacturing hub for optical fiber and cable.

“As Corning celebrates its 175th year, our partnership with Meta and today’s groundbreaking underscore the importance of our investments in U.S. manufacturing,” said Mike O’Day, Senior Vice President and General Manager, Corning Optical Communications. “North Carolina has been central to Corning’s optical manufacturing leadership for decades, supported by a highly skilled workforce and the strong, long-standing backing of state and local leaders. We’re grateful for those partnerships and proud to continue expanding advanced manufacturing capacity here to support the next generation of AI infrastructure.”

About Corning Incorporated

Corning (www.corning.com) is one of the world’s leading innovators in materials science, with a 175-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people’s lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning’s capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning’s markets include optical communications, mobile consumer electronics, display, automotive, solar, semiconductors, and life sciences.

Media Relations Contact:

John Arwood

(828) 320-3249

[email protected]

Investor Relations Contact:

Christopher Keenan

(607) 974-6716

[email protected]

KEYWORDS: North Carolina New York United States North America

INDUSTRY KEYWORDS: Data Management Commercial Building & Real Estate Technology Manufacturing Construction & Property Other Technology Other Manufacturing Artificial Intelligence Networks Internet Other Construction & Property

MEDIA:

Photo
Photo
Leaders from Corning, Meta, and state and local government break ground for Corning’s new cable manufacturing facility in Hickory, NC
Logo
Logo
Posted on

Cushman & Wakefield Recognized by Newsweek as One of America’s Greatest Workplaces for Women

Cushman & Wakefield Recognized by Newsweek as One of America’s Greatest Workplaces for Women

NEW YORK–(BUSINESS WIRE)–
Cushman & Wakefield (NYSE: CWK), a leading global real estate services firm, has been recognized by Newsweek as one of America’s Greatest Workplaces for Women 2026, earning five out of five stars. The annual award is presented by Newsweek in partnership with Plant-A Insights Group.

America’s Greatest Workplaces for Women 2026 were identified through a nationwide survey of more than 89,000 women employees, evaluated across 120 key performance indicators. This recognition reflects Cushman & Wakefield’s commitment to fostering an inclusive culture that enables colleagues to connect, lead and drive sustainable growth. Today, women represent 70% of the firm’s Board of Directors, and as highlighted in the firm’s 2024 Sustainability Report, women represent 53% of executives, 43% of people managers and 39% of the total workforce.

“Being recognized as one of America’s Greatest Workplaces for Women is a meaningful honor and a testament to our workplace culture,” said Nadine Augusta, Cushman & Wakefield’s Chief Impact Officer. “This recognition reflects the progress we continue to make in creating an environment where employees feel heard, valued and supported, and where opportunities are accessible to all. We’re proud of the progress we’ve made and grateful to those whose voices and experiences help shape our workplace every day.”

The full list of featured companies can be viewed on the Newsweek website.

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for occupiers and investors with approximately 53,000 employees in over 350 offices and nearly 60 countries. In 2025, the firm reported revenue of $10.3 billion across its core service lines of Services, Leasing, Capital markets, and Valuation and other. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit www.cushmanwakefield.com.

MEDIA CONTACT

Annie Wood

Director, Corporate Communications

817-456-6209

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Other Professional Services Women Commercial Building & Real Estate Construction & Property Finance Professional Services Consumer Business

MEDIA:

Logo
Logo
Posted on

Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Atara Biotherapeutics, Inc. (ATRA), Coty Inc. (COTY), Vital Farms, Inc. (VITL), and Super Micro Computer, Inc. (SMCI)

ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:


Atara Biotherapeutics, Inc. (ATRA)

The shareholder class action lawsuit filed against Atara Biotherapeutics, Inc. (“Atara”) (NASDAQ: ATRA) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding Atara’s manufacturing and tabelecleucel’s regulatory prospects between May 20, 2024 and January 9, 2026. If you purchased Atara shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/atara-biotherapeutics/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 22, 2026.


Coty Inc. (COTY)

The shareholder class action lawsuit filed against Coty Inc. (“Coty”) (NYSE: COTY) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding slowing growth in Coty’s Prestige fragrance segment between November 5, 2025 and February 4, 2026. If you purchased Coty shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/coty/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 22, 2026.


Vital Farms, Inc. (VITL)

The shareholder class action lawsuit filed against Vital Farms, Inc. (“Vital Farms”) (NASDAQ: VITL) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding the implementation of its new enterprise resource planning system between May 8, 2025 and February 26, 2026. If you purchased Vital Farms shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/vital-farms/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 26, 2026. 


Super Micro Computer, Inc. (SMCI)

The shareholder class action lawsuit filed against Super Micro Computer, Inc. (“Super Micro”) (NASDAQ: SMCI) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding Super Micro’s compliance with applicable export control laws and regulations between April 30, 2024 and March 19, 2026. If you purchased Super Micro shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/super-micro-computer/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 26, 2026. 

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]



Posted on

Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–
The 19(a) monthly distribution notices for Templeton Emerging Markets Income Fund(NYSE: TEI) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.

 

 

 

Estimated sources & percentages of distributions

Ticker

Time period

Per share distribution March

2026

Net Investment Income

Net realized short-term capital gains

Net realized long-term capital gains

Return of Capital

TEI

Current

$0.0475

$0.0475

$0.00

–

$0.00

 

Month

 

100.0%

0.0%

–

0.0%

 

12/31

$0.1425

$0.1029

$0.0155

–

$0.0241

 

Fiscal YTD

 

72.2%

10.9%

–

16.9%

The amounts and sources of distributions reported in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon a Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. Each Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

The table below provides information regarding distributions and total return performance for various periods through prior month end. Performance includes the deduction of management fees and administrative expenses, assumes reinvestment of distributions, and does not account for taxes.

Annualized

Cumulative

Ticker

5-year average annual total return at NAV*

Current distribution rate at NAV**

Fiscal YTD return at NAV***

Fiscal YTD distribution rate at NAV***

TEI (FYE 12/31)

7.35%

7.99%

 

6.88%

1.33%

* Ending on the last day of the month prior to the most recent distribution record date.

**As of the last day of the month prior to the most recent distribution record date.

***Calculated from the last completed fiscal year to the last day of the month prior to the most recent distribution record date.

You should not draw any conclusions about a Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s Distribution Policy.

Each fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’.

The Funds periodically provide fund-related information on their websites. The following information will be available for each Fund at www.franklintempleton.com at the frequencies indicated: (1) Full holdings will be available monthly; (2) Top 10 holdings and additional portfolio statistics will be available monthly.

INVESTMENT PRODUCTS: NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE

Copyright © 2026. Franklin Templeton. All rights reserved

Category: Distribution Related

Investor Contact: Fund Investor Services 1-888-777-0102

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Posted on

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) — PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.”

The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy.

Over the past eighteen months, more than $19 billion in deal value has been committed across the amylin space, with major pharmaceutical companies, including Novo Nordisk, Eli Lilly, Roche, Pfizer, and AbbVie, actively building positions.

The report highlights:

  • Nearly 40 amylin receptor agonist programs currently in development worldwide
  • The first GLP-1/amylin combination therapy approaching FDA decision
  • Clinical data demonstrating up to 20%+ weight loss with amylin-based therapies
  • The emergence of oral small-molecule amylin programs as a potential market-expanding force
  • The critical role of patent strategy in determining long-term competitive advantage

“We are witnessing the maturation of Amylin into the strategic bedrock of obesity therapeutics. In a world of converging efficacy, the value proposition is shifting from clinical data to patent depth. The winners won’t just be those with the best molecule, but those with the most sophisticated intellectual property architecture.” said Will Rosellini, Chief IP Officer at PatentVest.

The report also examines how the next 18 months, featuring major clinical readouts, regulatory decisions, and early-stage data, will reshape the competitive landscape.

PatentVest Pulse is an ongoing research series analyzing high-impact innovation trends at the intersection of biotechnology, intellectual property, and competitive strategy.

The full report is available now.

Access the report: https://insights.patentvest.com/https/www.patentvest.com/patentvest-pulse/the-amylin-renaissance-forty-programs-19-billion-in-deals-and-the-race-to-build-the-next-pillar-of-obesity-medicine.

About PatentVest

PatentVest provides strategic intelligence at the intersection of intellectual property, life sciences, and capital markets, helping investors and operators identify defensible innovation.

Media Contact:

For more information or inquiries, please contact [email protected].



Posted on

Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

SAN MATEO, Calif.–(BUSINESS WIRE)–
The 19(a) monthly distribution notices for Franklin Limited Duration Income Trust (NYSE: FTF) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share of common stock basis, and as a percentage of the distribution amount.

 

 

 

Estimated sources & percentages of distributions

Ticker

Time period

Per share

distribution

March

2026

Net

Investment

Income

Net realized

short-term

capital gains

Net realized

long-term

capital gains

Return of

Capital

FTF

Current

$0.0615

$0.0439

$0.0019

–

$0.0157

 

month

 

71.4%

3.1%

–

25.5%

 

12/31

$0.1845

$0.1284

$0.0082

–

$0.0479

 

Fiscal YTD

 

69.6%

4.4%

–

26.0%

The amounts and sources of distributions reported in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon a Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. Each Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

The table below provides information regarding distributions and total return performance for various periods through prior month end. Performance includes the deduction of management fees and administrative expenses, assumes reinvestment of distributions, and does not account for taxes.

Annualized

Cumulative

Ticker

5-year average

annual total

return at NAV*

Current

distribution

rate at

NAV**

Fiscal YTD

return at

NAV***

Fiscal YTD

distribution rate

at NAV***

FTF (FYE 12/31)

3.08%

11.32%

0.35%

1.89%

* Ending on the last day of the month prior to the most recent distribution record date.

**As of the last day of the month prior to the most recent distribution record date.

***Calculated from the last completed fiscal year to the last day of the month prior to the most recent distribution record date.

You should not draw any conclusions about a Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s Distribution Policy.

Each fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with ‘yield’ or ‘income’.

The Funds periodically provide fund-related information on their websites. The following information will be available for each Fund at www.franklintempleton.com at the frequencies indicated: (1) Full holdings will be available monthly; (2) Top 10 holdings and additional portfolio statistics will be available monthly.

INVESTMENT PRODUCTS: NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE

Copyright © 2026. Franklin Templeton. All rights reserved

Category: Distribution Related

Investor Contact: Fund Investor Services 1-888-777-0102

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Asset Management Professional Services Finance

MEDIA:

Posted on

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

US PTAB Revokes Sole Independent and Other Central Claims of U.S. Patent 11,435,360

SCHLIEREN, Switzerland & MUNICH–(BUSINESS WIRE)–
PreOmics GmbH and Biognosys AG today announced a favorable outcome in an inter partes review (IPR) proceeding IPR2024‑01473 before the U.S. Patent Trial and Appeal Board (PTAB). The PTAB has revoked the central claims of U.S. Patent No. 11,435,360, which is owned by The Brigham and Women’s Hospital, and exclusively licensed to Seer, Inc.

The USPTO struck down the sole independent claim of the ‘360 patent, among other claims. The PTAB specifically invalidated Claim 1, which attempted to cover workflows using multiple nanoparticle types to form biomolecule coronas and detect proteins across a wide dynamic range.

“This outcome confirms what we have consistently believed from the outset: the fundamental concepts at issue were already known in the scientific literature,” said Dr. Oliver Rinner, co-founder and managing director of Biognosys AG. “We welcome the PTAB’s thorough evaluation and we are very pleased with this clear result.”

PreOmics and Biognosys remain committed to advancing high‑performance sample preparation and software for proteomics and multiomics workflows for researchers worldwide.

About Biognosys and PreOmics

Biognosys and PreOmics are part of the Biognosys Group that delivers high-performance, robust solutions across proteomics, metabolomics, and lipidomics — driving innovation at the forefront of multiomics. Building on the combined strengths of PreOmics, Biognosys, and biocrates, Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows seamless, scalable, and accessible to every laboratory. The Biognosys Group maintains a vendor-neutral strategy, ensuring open and flexible collaboration across the scientific community and broad compatibility of its solutions across the major mass spectrometry platforms. Designed for agility, our technologies can operate independently or within a unified ecosystem, supported by flexible business models and a strong commitment to partnership. PreOmics GmbH and Biognosys AG are subsidiaries of Bruker Corporation (Nasdaq: BRKR).

Media contact:

Oliver Rinner

SVP Biognosys Group

[email protected]

KEYWORDS: Massachusetts North America United States Switzerland Europe Germany

INDUSTRY KEYWORDS: Professional Services Patent Law Health Legal Health Technology Pharmaceutical

MEDIA:

Posted on

Holzer & Holzer, LLC Reminds Investors of Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Gemini Space Station, Inc. (GEMI), Hercules Capital, Inc. (HTGC), Power Solutions International, Inc. (PSIX), and Lufax Holding Ltd (LU)

ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:


Gemini Space Station, Inc. (GEMI)

The shareholder class action lawsuit filed against Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts, including allegations that Gemini overstated the viability of its core business as a crypto platform between September 12, 2025 and February 17, 2026. If you purchased Gemini shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/gemini-space-station/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is 
May 18, 2026.


Hercules Capital, Inc. (HTGC)

The shareholder class action lawsuit filed against Hercules Capital, Inc. (“Hercules Capital”) (NYSE: HTGC) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding the due diligence with which Hercules Capital conducted its deal sourcing and/or loan origination process and/or its portfolio valuation process between May 1, 2025 and February 27, 2026. If you purchased Hercules Capital shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/hercules-capital/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is May 19, 2026.


Power Solutions International, Inc. (PSIX)

The shareholder class action lawsuit filed against Power Solutions International, Inc. (“Power Solutions”) (NASDAQ: PSIX) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding Power Solutions’ ability to capture sales demand for its power systems solutions, particularly within the data center market between May 8, 2025 and March 2, 2026. If you purchased Power Solutions shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/power-solutions-international/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is
May 19, 2026.


Lufax Holding Ltd (LU)

The shareholder class action lawsuit filed against Lufax Holding Ltd (“Lufax”) (NYSE: LU) alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material facts regarding Lufax’s internal controls and financial results between April 7, 2023 and January 26, 2025. If you purchased Lufax shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/lufax-holding/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is 
May 20,
2026.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]